Podcast Episodes

Back to Search
The Ron Lanton Report: Where Innovations Happens
The Ron Lanton Report: Where Innovations Happens

In this episode, Ron Lanton examines how geography is becoming a central strategic variable in healthcare, as policy, trade dynamics, and infrastruct…

6 months, 3 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: Idvynso Receives FDA Approval
Pharmaceutical Executive Daily: Idvynso Receives FDA Approval

In today’s Pharmaceutical Executive Daily, the FDA approves a new treatment for HIV-1 infection in adults, Amazon One Medical launches a GLP-1 weight…

6 months, 3 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: UnitedHealth Raises Full-Year Profit Forecast
Pharmaceutical Executive Daily: UnitedHealth Raises Full-Year Profit Forecast

In today’s Pharmaceutical Executive Daily, UnitedHealth raises its full-year profit forecast following stronger-than-expected first-quarter results, …

6 months, 4 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: Eli Lilly Acquires Kelonia Therapeutics
Pharmaceutical Executive Daily: Eli Lilly Acquires Kelonia Therapeutics

In today’s Pharmaceutical Executive Daily, Eli Lilly enters a $7 billion agreement to acquire Kelonia Therapeutics, the Trump administration issues a…

6 months, 4 weeks ago

Short Long
View Episode
Inside Pharma's Revenue Engine: The Gross-to-Net Reckoning
Inside Pharma's Revenue Engine: The Gross-to-Net Reckoning

In the debut episode of Pricing & Policy with Model N — a new podcast series from Pharmaceutical Executive — Model N VP of product management Michae…

7 months ago

Short Long
View Episode
Pharmaceutical Executive Daily: Eli Lilly Releases Updated Safety Data for Foundayo
Pharmaceutical Executive Daily: Eli Lilly Releases Updated Safety Data for Foundayo

In today's Pharmaceutical Executive Daily, Eli Lilly releases updated safety data for its oral obesity pill Foundayo in response to an FDA post-appro…

7 months ago

Short Long
View Episode
Pharmaceutical Executive Daily: Obsidian and Galera Therapeutics Enter Merger Agreement
Pharmaceutical Executive Daily: Obsidian and Galera Therapeutics Enter Merger Agreement

In today’s Pharmaceutical Executive Daily, platform innovation continues to drive biotech investment across oncology and immunology, Obsidian Therape…

7 months ago

Short Long
View Episode
Pharmaceutical Executive Daily: AbbVie and Haisco Enter $745 Million Licensing Agreement
Pharmaceutical Executive Daily: AbbVie and Haisco Enter $745 Million Licensing Agreement

In today's Pharmaceutical Executive Daily, AbbVie licenses a portfolio of pain compounds from China's Haisco Pharmaceutical in a deal worth up to $74…

7 months ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Issues Second CRL for Replimune's RP1 Melanoma Treatment
Pharmaceutical Executive Daily: FDA Issues Second CRL for Replimune's RP1 Melanoma Treatment

In today's Pharmaceutical Executive Daily, the FDA issues a second complete response letter for Replimune's RP1 in advanced melanoma, Regeneron and T…

7 months ago

Short Long
View Episode
Pharmaceutical Executive Daily: China Approves Amgen's Tarlatamab for Previously Treated Extensive-Stage Small Cell Lung Cancer
Pharmaceutical Executive Daily: China Approves Amgen's Tarlatamab for Previously Treated Extensive-Stage Small Cell Lung Cancer

In today's Pharmaceutical Executive Daily, China approves Amgen's tarlatamab for previously treated extensive-stage small cell lung cancer, a large s…

7 months, 1 week ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us